Effects of a Microbiome-Targeted Diet on Cardiometabolic Risk in People Living with HIV: A Randomized Controlled Trial with Mediation Analysis
Background Cardiovascular disease (CVD) is a leading cause of morbidity among people living with HIV (PLWH), partly driven by gut microbiome dysbiosis. Whether microbiome-targeted dietary interventions can reduce CVD risk in this population remains unclear. We aimed to evaluate the effectiveness of a microbiome-targeted dietary intervention on CVD risk and gut microbiome in PLWH and to examine potential microbial mediation. Methods We conducted a 12-week, single-blind, parallel-group randomized controlled trial in PLWH with elevated CVD risk in China. Participants were assigned to a microbiome-targeted diet (n=29), consisting of a culturally adapted, polyphenol-rich dietary pattern supplemented with Spirulina, or a control group receiving standard dietary advice (n=31). The primary outcome was 10-year CVD risk estimated via pooled cohort equations (PCE). Secondary outcomes included cardiometabolic biomarkers and gut microbiota profiles assessed by 16S rRNA sequencing. Exploratory mediation analyses were conducted to evaluate indirect associations involving microbial taxa. Results In the primary analysis, the intervention was associated with reductions in PCE-estimated ASCVD risk (P=0.024), systolic blood pressure (P<0.001), and self-reported CVD symptoms (P=0.001). It also increased α-diversity and induced compositional shifts, with decreased Klebsiella, Enterobacteriaceae, and Escherichia-Shigella, and increased Prevotella stercorea, Faecalibacterium, and Sutterella wadsworthensis. Exploratory mediation analyses identified significant indirect effects involving Prevotella stercorea (βindirect[95% CI]=-1.905 [-4.618, -0.064]) for SBP and Methanobrevibacter smithii (-1.804 [-4.428, -0.024]) for DBP. Conclusions A culturally tailored, microbiome-targeted dietary intervention showed potential cardiometabolic benefits among PLWH. Exploratory indirect-effect analyses suggested possible microbiome-related pathways, which require confirmation in longitudinal and mechanistic studies. Microbiome-informed dietary strategies may be promising, non-pharmacologic approaches for CVD prevention in HIV care.
Authors
- Junwen Yu (ORCID: https://orcid.org/0000-0001-5069-6411)
- Bei Wu (ORCID: https://orcid.org/0000-0002-6891-244X)
- Zheng Zhu (ORCID: https://orcid.org/0000-0001-9651-8311)
- Hongzhou Lu (ORCID: https://orcid.org/0000-0002-8308-5534)
- Xiaoning Liu (ORCID: https://orcid.org/0000-0001-6833-3643)
- Xiang Qi
- Changrong Yuan
Institutions
- Fudan University (CN)
- New York University Shanghai (CN)
- Shenzhen Third People’s Hospital (CN)
- New York University (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1093/ofid/ofag703
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00